"Texas Heart Institute (THI) is a nonprofit organization dedicated to delivering the future of cardiovascular health through exceptional patient care, discovery, and a commitment to learning."

During the past decade, Texas Heart Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 20 clinical trials were completed, i.e. on average, 117.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Heart Institute" #1 sponsor was "Abbott Medical Devices" with 8 trials, followed by "The University of Texas Health Science Center, Houston" with 6 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "Abiomed Inc." with 2 trials sponsored and "Cubist Pharmaceuticals LLC" with 2 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Heart Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "Thoratec Corporation" with 5 trials as a collaborator, "Clinipace Worldwide" with 2 trials as a collaborator, "Acelis Connected Health" with 1 trials as a collaborator and "Aldagen" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Texas Heart Institute" are "Heart Failure" (13 trials), "Cardiac Surgery" (4 trials), "Chronic Heart Failure" (4 trials), "Ventricular Dysfunction" (4 trials) and "Heart Failure, Congestive" (3 trials). Many other conditions were trialed in "Texas Heart Institute" in a lesser frequency.

Most popular intervention types in "Texas Heart Institute" are "Device" (26 trials), "Biological" (15 trials), "Drug" (14 trials), "Other" (6 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Adult stem cells" (3 trials), "HeartWare® VAS" (3 trials), "placebo" (3 trials) and "Control LVAD" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Heart Institute" are 59 trials for "All" genders.

Currently, there are NaN active trials in "Texas Heart Institute". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Texas Heart Institute, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Heart Institute, 5 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 18 trials that are defined as “Not Applicable".

Texas Heart Institute has several departments that took part in Clinical trials: "Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266" - 2 trials